Michael Biggins

Michael Biggins is an experienced professional in the pharmaceutical and healthcare sectors, currently serving as a Nephrology Strategic Account Manager at Horizon since August 2019, where responsibility includes launching KRYSTEXXA to nephrologists in South Florida and Puerto Rico. Prior to this role, Michael held various positions including Specialty Account Manager at Questcor Pharmaceuticals/Mallinckrodt Pharmaceuticals from September 2012 to August 2019, Executive Acthar Specialist at Human Genome Sciences from October 2010 to October 2012, Account Manager at Merz Pharmaceuticals for a brief period in 2010, and Territory Business Manager at Bristol-Myers Squibb from 2005 to 2010. Michael holds a degree from PennWest Clarion, earned between 1995 and 2000.